Published in Int J Clin Exp Pathol on January 01, 2015
RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis. Oncotarget (2016) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature (2008) 75.40
Cancer statistics, 2007. CA Cancer J Clin (2007) 53.49
Mechanisms underlying ubiquitination. Annu Rev Biochem (2001) 18.87
The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol (2002) 8.62
WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer (2013) 6.64
Glioblastoma and other malignant gliomas: a clinical review. JAMA (2013) 4.99
Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling. J Biol Chem (2002) 3.34
Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science (2005) 3.22
DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway. Oncogene (2004) 2.73
RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary. J Pathol (2013) 1.20
RNF43 interacts with NEDL1 and regulates p53-mediated transcription. Biochem Biophys Res Commun (2010) 1.11
[The 4th Edition of WHO Classification of Tumours of the Central Nervous System published in 2007]. No Shinkei Geka (2008) 0.86
Identification of two Wnt-responsive elements in the intron of RING finger protein 43 (RNF43) gene. PLoS One (2014) 0.85
Gliomas: correlation of histologic grade, Ki67 and p53 expression with patient survival. Asian Pac J Cancer Prev (2010) 0.85
miR-96/HBP1/Wnt/β-catenin regulatory circuitry promotes glioma growth. FEBS Lett (2014) 0.84
The role of the ubiquitin-proteasome pathway in cancer development and treatment. Front Biosci (Landmark Ed) (2014) 0.84
Retracted The impact of survivin on prognosis and clinicopathology of glioma patients: a systematic meta-analysis. Mol Neurobiol (2014) 0.84